
International Congress on Structural Epilepsy & Symptomatic Seizures 2025
Wallenberg Centre in Gothenburg, Sweden
2 - 4 April 2025
ILAE Curriculum Learning Objectives addressed by this course
- 1.1.1 Describe the major etiologies for epilepsy (i.e. structural, genetic, infectious, metabolic, immune, and neurodegenerative) (L1)
- 1.1.2 Describe the common structural etiologies
- 1.1.4 Describe the common infectious causes of epilepsy, including geographical impacts (e.g. bacterial, fungal, viral, parasites) (L2)
- 1.1.5 Describe the common metabolic causes of epilepsy
- 1.1.6 Describe the common immune causes of epilepsy
- 1.1.7 Describe the common neurodegenerative causes of epilepsy
- 1.3.1 Learn and recognize the seizure semiology and distinguish it from other non-epileptic manifestations
- 1.3.2 Extract semiology information from patient history
- 1.4.1 Determine whom should receive EEGs, be familiar with sensitivity and specificity, and how to interpret the report in the clinical context (L1)
- 1.4.6 Recognize the different types of EEG recordings and methodologies
- 1.4.8 Recognize and distinguish artifacts and normal variants from abnormal EEG patterns, and take actions necessary for eliminating artifacts (L2)
- 1.5.2 Decide on whom to do structural neuroimaging (L1)
- 1.6.1 Decide which patients should receive lab tests and which types of tests should be ordered (L1)
- 1.7.1 Accurately distinguish acute symptomatic seizures from epilepsy (L1)
- 1.7.2 Correctly distinguish between focal and generalized epilepsies and recognize epileptic encephalopathies (L1)
- 1.7.3 Correctly diagnose and classify focal epilepsies (L2)
- 2.8.1 Identify and provide counseling on issues related to comorbidities (L2)
- 2.8.2 Identify and provide counseling on issues related to drug interactions (L2)
- 6.2.1 Diagnose somatic comorbidities, such as those related to epilepsy treatment, causes of epilepsy, or common associated conditions (L2)
- 6.2.2 Appropriately manage and advise regarding somatic comorbidities (L2)
- 6.2.3 Adjust anti-seizure treatment as required by common somatic comorbidities (L2)
- 7.2.1 Demonstrate working knowledge of epileptogenesis (L3)
- 7.3.1 Demonstrate awareness of animal models for focal and generalized epilepsies (L3)
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community